ArticleThe Journal of international medical research2018

Nuclear G protein-coupled oestrogen receptor (GPR30) predicts poor survival in patients with ovarian cancer.

Cai-Xia Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.